Legal & General Group’s Neurogene NGNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.4K | Sell |
898
-332
| -27% | -$4.96K | ﹤0.01% | 3172 |
|
|
2025
Q1 | $14.4K | Buy |
1,230
+208
| +20% | +$2.44K | ﹤0.01% | 3060 |
|
|
2024
Q4 | $23.4K | Hold |
1,022
| – | – | ﹤0.01% | 2970 |
|
|
2024
Q3 | $42.9K | Hold |
1,022
| – | – | ﹤0.01% | 2809 |
|
|
2024
Q2 | $37.2K | Buy |
+1,022
| New | +$37.2K | ﹤0.01% | 2835 |
|
|
2022
Q2 | – | Sell |
-152
| Closed | -$6K | – | 3610 |
|
|
2022
Q1 | $6K | Hold |
152
| – | – | ﹤0.01% | 3489 |
|
|
2021
Q4 | $15K | Sell |
152
-389
| -72% | -$38.4K | ﹤0.01% | 3366 |
|
|
2021
Q3 | $78K | Buy |
541
+332
| +159% | +$47.9K | ﹤0.01% | 2893 |
|
|
2021
Q2 | $39K | Sell |
209
-35
| -14% | -$6.53K | ﹤0.01% | 3033 |
|
|
2021
Q1 | $60K | Sell |
244
-10
| -4% | -$2.46K | ﹤0.01% | 2763 |
|
|
2020
Q4 | $71K | Hold |
254
| – | – | ﹤0.01% | 2687 |
|
|
2020
Q3 | $61K | Sell |
254
-49
| -16% | -$11.8K | ﹤0.01% | 2625 |
|
|
2020
Q2 | $100K | Buy |
+303
| New | +$100K | ﹤0.01% | 2534 |
|